1 results match your criteria: "Canada Hospital for Special Surgery[Affiliation]"
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis.
Ann Rheum Dis
June 2016
Mount Sinai Hospital, Toronto, Ontario, Canada Hospital for Special Surgery, New York, New York, USA.
Objective: To determine the comparative effectiveness of oral versus subcutaneous methotrexate (MTX) as initial therapy for patients with early rheumatoid arthritis (ERA).
Methods: Patients with ERA (symptoms ≤1 year) initiating MTX therapy were included from a multicentre, prospective cohort study. We compared the effectiveness between starting with oral versus subcutaneous MTX over the first year.